<DOC>
	<DOCNO>NCT00341913</DOCNO>
	<brief_summary>Reduced susceptibility Staphyloccus aureus glycopeptide antibiotic vancomycin cause increase concern worldwide view threat increase morbidity mortality cause resistant organism . MRL Pharmaceutical Services , Division Focus/MRL , contract NIAID establish Network Antimicrobial Resistance S. aureus ( NARSA ) document case staphylococcal isolates reduce susceptibility vancomycin ( MIC 's great equal 4 micrograms/ml ) arise procure isolate central repository distribution register approved researcher . MRL responsible contact site isolates report discuss test method use determine reduce vancomycin susceptibility status isolate . Once MRL Laboratory determine isolate meet criterion state , site ask ship isolate MRL possible candidate inclusion NARSA Repository . The procurement strategy involve issue isolate temporary strain designation number destroy antibiotic profile isolate confirm MRL , thus prevent link data generate site . The isolate antimicrobial susceptibility profile several key drug record NARSA Repository database . Demographic information relate isolate collect site include : The Name Donor Site/Institution , City ( hold separate secure database , data point available registered user ) ; State , Country Donor Site ; Isolation Date ; Age ; Sex ; Patient Location ; Patient Service ; Culture Source ; Reporting History . This information hold Registry database . Since patient-specific information collect , request waiver inform consent request herein . NIAID fund investigator ( NARSA Core Investigators ) approve registered user whose research focus S. aureus access Registry/Repository database able request isolates use research . Facility specific information hold separate secure database available register researcher unless approve IRB review .</brief_summary>
	<brief_title>Network Antimicrobial Resistance Staphylococcus Aureus</brief_title>
	<detailed_description>Reduced susceptibility Staphyloccus aureus glycopeptide antibiotic vancomycin cause increase concern worldwide view threat increase morbidity mortality cause resistant organism . MRL Pharmaceutical Services , Division Focus/MRL , contract NIAID establish Network Antimicrobial Resistance S. aureus ( NARSA ) document case staphylococcal isolates reduce susceptibility vancomycin ( MIC 's great equal 4 micrograms/ml ) arise procure isolate central repository distribution register approved researcher . MRL responsible contact site isolates report discuss test method use determine reduce vancomycin susceptibility status isolate . Once MRL Laboratory determine isolate meet criterion state , site ask ship isolate MRL possible candidate inclusion NARSA Repository . The procurement strategy involve issue isolate temporary strain designation number destroy antibiotic profile isolate confirm MRL , thus prevent link data generate site . The isolate antimicrobial susceptibility profile several key drug record NARSA Repository database . Demographic information relate isolate collect site include : The Name Donor Site/Institution , City ( hold separate secure database , data point available registered user ) ; State , Country Donor Site ; Isolation Date ; Age ; Sex ; Patient Location ; Patient Service ; Culture Source ; Reporting History . This information hold Registry database . Since patient-specific information collect , request waiver inform consent request herein . NIAID fund investigator ( NARSA Core Investigators ) approve registered user whose research focus S. aureus access Registry/Repository database able request isolates use research . Facility specific information hold separate secure database available register researcher unless approve IRB review .</detailed_description>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>INCLUSION AND EXCLUSION CRITERIA : This study concern collection data antimicrobial phenotype bacterial isolates patient ( ) isolate . Therefore , criterion inclusion exclusion patient apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 17, 2008</verification_date>
	<keyword>Research</keyword>
	<keyword>Repository</keyword>
	<keyword>Registry</keyword>
	<keyword>Surveillance</keyword>
	<keyword>Databases</keyword>
</DOC>